Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Phytotherapy (BNO 1045) of Acute Lower Uncomplicated Urinary Tract Infection in Women Normalizes Local Host Responses

Butler, Daniel S.C. LU ; Wagenlehner, Florian ; Höller, Martina ; Abramov-Sommariva, Dimitri ; Steindl, Hubert and Naber, Kurt G. (2023) In Urologia Internationalis 107(8). p.778-784
Abstract

Introduction: Acute lower uncomplicated urinary tract infection (uUTI) affects a large proportion of women. Increased antimicrobial resistance has created an urgent need for novel therapeutics and the phytotherapeutic drug BNO 1045 (Canephron® N) has previously been shown to be noninferior to standard antimicrobial stewardship. This sub-analysis from a randomized, double-blind, controlled phase III noninferiority clinical trial using BNO 1045 versus fosfomycin to treat uUTI aimed to determine how urine cytokine levels are altered by the two different treatments. Methods: Urine samples from a predefined subset of women diagnosed with uUTI (18-70 years) and treated with BNO 1045 (n = 58) or fosfomycin (n = 69) were analyzed for... (More)

Introduction: Acute lower uncomplicated urinary tract infection (uUTI) affects a large proportion of women. Increased antimicrobial resistance has created an urgent need for novel therapeutics and the phytotherapeutic drug BNO 1045 (Canephron® N) has previously been shown to be noninferior to standard antimicrobial stewardship. This sub-analysis from a randomized, double-blind, controlled phase III noninferiority clinical trial using BNO 1045 versus fosfomycin to treat uUTI aimed to determine how urine cytokine levels are altered by the two different treatments. Methods: Urine samples from a predefined subset of women diagnosed with uUTI (18-70 years) and treated with BNO 1045 (n = 58) or fosfomycin (n = 69) were analyzed for urine levels of IL-6 and IL-8, using analyte-to-creatinine ratios. Results: BNO 1045 treatment showed similar effects to fosfomycin treatment in reducing both urine IL-6 and IL-8 levels. Mean IL-6 and IL-8 levels were markedly reduced in all patients regardless of treatment. BNO 1045 treatment decreased urine IL-8 significantly (p = 0.0142) and showed a trend toward reduction of urine IL-6 (p = 0.0551). Fosfomycin treatment reduced both IL-6 and IL-8 levels significantly (p = 0.0038, <0.0001 respectively). Conclusion: BNO 1045 is, in addition to reducing symptoms, comparable to fosfomycin treatment in reducing the local inflammatory response associated with uUTI.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; and
publishing date
type
Contribution to journal
publication status
published
keywords
BNO 1045, Phytotherapy, Uncomplicated urinary tract infection, Urine cytokines
in
Urologia Internationalis
volume
107
issue
8
pages
778 - 784
publisher
Karger
external identifiers
  • pmid:37544300
  • scopus:85170582392
ISSN
0042-1138
DOI
10.1159/000531206
language
English
LU publication?
no
additional info
Publisher Copyright: © 2023 S. Karger AG. All rights reserved.
id
1fa10737-b3d0-45fa-8f4e-685f0b580c86
date added to LUP
2026-09-09 15:43:23
date last changed
2026-09-10 08:12:08
@article{1fa10737-b3d0-45fa-8f4e-685f0b580c86,
  abstract     = {{<p>Introduction: Acute lower uncomplicated urinary tract infection (uUTI) affects a large proportion of women. Increased antimicrobial resistance has created an urgent need for novel therapeutics and the phytotherapeutic drug BNO 1045 (Canephron<sup>®</sup> N) has previously been shown to be noninferior to standard antimicrobial stewardship. This sub-analysis from a randomized, double-blind, controlled phase III noninferiority clinical trial using BNO 1045 versus fosfomycin to treat uUTI aimed to determine how urine cytokine levels are altered by the two different treatments. Methods: Urine samples from a predefined subset of women diagnosed with uUTI (18-70 years) and treated with BNO 1045 (n = 58) or fosfomycin (n = 69) were analyzed for urine levels of IL-6 and IL-8, using analyte-to-creatinine ratios. Results: BNO 1045 treatment showed similar effects to fosfomycin treatment in reducing both urine IL-6 and IL-8 levels. Mean IL-6 and IL-8 levels were markedly reduced in all patients regardless of treatment. BNO 1045 treatment decreased urine IL-8 significantly (p = 0.0142) and showed a trend toward reduction of urine IL-6 (p = 0.0551). Fosfomycin treatment reduced both IL-6 and IL-8 levels significantly (p = 0.0038, &lt;0.0001 respectively). Conclusion: BNO 1045 is, in addition to reducing symptoms, comparable to fosfomycin treatment in reducing the local inflammatory response associated with uUTI.</p>}},
  author       = {{Butler, Daniel S.C. and Wagenlehner, Florian and Höller, Martina and Abramov-Sommariva, Dimitri and Steindl, Hubert and Naber, Kurt G.}},
  issn         = {{0042-1138}},
  keywords     = {{BNO 1045; Phytotherapy; Uncomplicated urinary tract infection; Urine cytokines}},
  language     = {{eng}},
  month        = {{09}},
  number       = {{8}},
  pages        = {{778--784}},
  publisher    = {{Karger}},
  series       = {{Urologia Internationalis}},
  title        = {{Phytotherapy (BNO 1045) of Acute Lower Uncomplicated Urinary Tract Infection in Women Normalizes Local Host Responses}},
  url          = {{http://dx.doi.org/10.1159/000531206}},
  doi          = {{10.1159/000531206}},
  volume       = {{107}},
  year         = {{2023}},
}